Updated on 11/22/2021 12:03 pm Pfizer’s COVID vaccine remains 100% effective in adolescents 12 to 15 years of age more than four months after the second dose is applied, the company reported Monday, according to updated data that it hopes will allow full authorization of the immunizer for this range. age. The Pfizer-BioNTech vaccine currently […]
Tag: Pfizer
Profits from Pfizer, BioNTech and Moderna amount to US $ 65,000 per minute due to COVID-19
According to a new analysis of the Popular Alliance for Vaccines (PVA), the companies Pfizer, BioNTech and Moderna collectively earn $ 65,000 every minute from their COVID-19 vaccines. However, in the poorest countries in the world they still do not immunize their inhabitants. With an estimate of more than $1,000 dollars per secondAt US $ […]
Adults who want to can now receive booster doses in the US.
From this Friday the adults who want to can receive the booster dose of the vaccines against the COVID-19 of Pfizer and Moderna in USA, after they were approved by the country’s health authorities. The last missing step was taken on Friday afternoon by the director of the Centers for Disease Control and Prevention (CDC, […]
US orders Pfizer 10 million pills against COVID-19 for US $ 5.3 billion
The US government ordered from the pharmaceutical giant Pfizer 10 million pills against COVID-19 for US $ 5.29 billion, an order contingent on the approval of the drug by the competent authorities. Pfizer on Tuesday petitioned the Food and Drug Administration (FDA) authorization for the emergency use of its Paxlovid pill, which has been shown […]
US Close to Expanding COVID-19 Booster Use to All Adults
An influential U.S. advisory panel will discuss on Friday the possibility of expanding eligibility for the booster dose of the COVID-19 vaccine to all adults. Some cities and states already allow all adults to receive the booster dose of the vaccine against the COVID-19 developed by Pfizer, but it is not yet an official federal […]
Pfizer requests authorization of the COVID-19 pill in the United States
Updated on 11/16/2021 02:56 pm Pfizer Inc announced that it is requesting authorization in USA for his experimental antiviral pill for the COVID-19, which reduced the chance of hospitalization or death for adults at risk of serious illness by 89% in a clinical trial. Pfizer stated that it completed the submission of its application for […]
Pfizer and Medicines Patent Pool to facilitate global access to pharmaceutical company anti-COVID pill
Updated on 11/16/2021 07:47 am Pfizer has signed a voluntary license agreement that should allow access to its anti-COVID pill beyond rich countries once it has been licensed, the US pharmaceutical giant and the Medicines Patent Pool (MPP) announced Tuesday. Manufacturers of generic drugs “that receive sublicenses will be able to offer the new drug […]
Pfizer asks US for authorization of third dose of its vaccine against COVID-19 for adults
Updated on 11/09/2021 07:05 pm Pfizer and BioNTech announced that they have formally submitted an application to the Food and Drug Agency (FDA) to authorize the emergency use of a third dose of your vaccine against COVID-19 for people over 18 years old. The companies reported in late October that clinical trials conducted on 100,000 […]
Pfizer’s anti-COVID pill could be a promising “tipping point” in the pandemic
Pfizer presented on the eve (Friday) a pill that reduces the risk of death by almost 90% from COVID-19 for those infected with comorbidities, a promising result that its executives believe will lead to a “tipping point” in the fight against the pandemic. The pharmaceutical company revealed in a statement preliminary data from a study […]
Pfizer CEO Says In Talks With 90 Countries To Sell COVID-19 Pill
Updated on 05/11/2021 05:07 pm Pfizer Inc is in talks with 90 countries on supply contracts for its experimental pill for the COVID-19, which was shown to reduce the risk of hospitalization or death by 89% in patients at high risk of severe disease, said its CEO Albert Bourla. He argued that Pfizer hopes to […]